HCP, Inc. (HCP) Technical Analysis: What Are The Charts Saying?

Considering all key technical indicators, a 64% Buy signal has occurred for HCP, Inc. (NYSE:HCP). The stock is also flashing a Buy from the Barchart TrendSpotter trading system. Traders hoping to speculate on the HCP’s short-term trajectory should know that short terms indicators for the stock averaged 20% Buy with an average daily trading volume over the past 20 days at 3829835 shares. HCP stock has overall a 0.75% Buy signal considering medium term indicators and the 50-day average daily volume remained almost 3252342 shares. It’s also worth noting that the stock, whose average daily volume over the 100 days prior to this writing was shares, is 100% Buy on the basis of long term indicators.

The share price is currently staying around the first support level of $28.37. Below this, the next support is placed in the zone of $28.01. Till the time, the HCP stock trades above this level, bulls have nothing to fear. On momentum oscillators front, ‘RSI’ has touched 63.72 on daily chart, which may remain a cause for concern. If the price breaks below $28.01 level on closing basis, then we may see more profit booking and the stock may show further weakness. On the flipside, hitting the $28.99 mark may result into a pull-back move towards $29.25 level.

HCP, Inc. (HCP) is projected to climb by -2.57 percent over the next 12 months, according to price target estimates compiled by finviz. Meanwhile, they have set a $32 as 1-year high price target. This represents a whopping 11.34 percent increase from where shares are trading today. The 12-month median price target assigned by the analysts stands at $28, which represents a return potential of -2.57 percent when compared to the closing price of the stock of $28.74 on Monday, November 26. The lowest price target for the stock is $24 — slightly more than -16.49 percent from HCP’s current share price.

Here’s a rundown of insider trading activity for sense of HCP, Inc. (NYSE:HCP). The earliest insider trade took place on 05/14/2018. Griffin R Kent Jr gathered a total of 21.1 thousand shares of company at average share price of $23.8. The total for the purchase was set at $502.18 thousand. After this transaction, the Director account balance stood at 30.58 thousand shares. The stock grew 20.76 percent since that insider purchase. On 02/14/2018, Young Kendall K, Senior Managing Director, purchased 14 thousand shares at a price per share of $21.91. This added 306.74 thousand shares to the insider’s fortune and the stock saw a 31.17 percent rally in value since the news became public. This transaction left 62.54 thousand shares in the Senior Managing Director account. On 06/13/2017, Senior Managing Director Klaritch Thomas performed a sale transaction worth $83.59 thousand. This sale at $31.53 each has eliminated 2.65 thousand shares from the insider’s portfolio position. Meanwhile, shares have recorded -8.85 percent decrease since the transaction was reported. The insider now is left with 176.83 thousand shares remaining in the account. Anderson Scott A, who performs the EVP and CAO job, sold 10 thousand shares for $299.4 thousand. The disposal occurred on 03/16/2017 was priced at $29.94 per share. The share price plunged -4.01 percent since the reporting date. Anderson Scott A now left with a stake of 27.35 thousand HCP stock worth $785.9 thousand after the insider selling.

HCP shares dropped -0.02 points or -0.07 percent on Monday to $28.74 with a heavy trade volume of 3.387 million shares. After opening the session at $28.88, the shares went as high as $28.88 and as low as $28.26, the range within which the stock’s price traded throughout the day. The firm is left with a market cap of $13.6 billion and now has 471.55 million shares outstanding. HCP, Inc. (HCP) stock has gained 6.33 percent of market value in 21 trading days.

Analysts at RBC Capital Mkts upped their rating on shares of HCP, Inc. (NYSE:HCP) from Sector Perform to Outperform in their opinion released on November 02. JP Morgan analysts have downgraded their rating of HCP stock from Overweight to Neutral in a separate flash note to investors on October 05. Analysts at Cantor Fitzgerald issued an upgrade from Neutral to Overweight for the stock, in a research note that dated back to September 28.

HCP stock has a trailing 3-year beta of 0.16, offering the possibility of a lower rate of return, but also posing less risk. The portion of a company’s profit allocated to each outstanding share of common stock was $0.4 a share in the trailing twelve months. The stock’s value has surged 10.2 percent year to date (YTD) against a rise of 6.92 percent in 12 month’s time. The company’s shares still trade -1.98 percent away from its 1-year high of $29.32 and 33.8 percent up from 52-week low of $21.48. The average consensus rating on the company is 2.7, on a scale where 5 equates to a unanimous sell rating. In short, the mean analyst recommendations are calling this stock a sell.

Shares of HCP, Inc. (HCP) are trading at a P/E ratio of 72.76 times earnings reported for the past 12 months. The industry HCP operates in has an average P/E of 47.56. Its P/E ratio went as low as 16.84X and as high as 116.3 over the 5-year span. Further, it is sporting a 7.33 on the Price-to-Sales ratio. Compare this with the industry average P/S of 8.24. 60.7 percent is the gross profit margin for HCP, Inc. and operating margin sits at 16.6 percent. Along with this, the net profit margin is 9.1 percent.

HCP will be declaring its Q4 financial results on February 12. Analysts are forecasting revenue to climb 0.8 percent to $447M in the next fiscal quarter, while earnings are seen soaring by nearly -192.31 percent to $0.12 per share. History has shown that shares in HCP, Inc. have gone down on 20 different earnings reaction days and are predicted to add 0.02 percent when the company reports upcoming earnings. In last reported earnings results, it earned $0.21 per share, better than the $0.11, adjusted, expected by Thomson Reuters consensus estimate. Revenue was $456M, better than the $450M analysts expected. Earnings are estimated to increase by 18.8 percent this year, 7.95 percent next year and continue to increase by 2.5 percent annually for the next 5 years.